Advances in anti-inflammatory therapy

Acta Medica Austriaca

Volumn 29, Issue 1, 2002, Pages 1-6

  Aletaha, Daniel ^a   Smolen, J S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

GI protection; NSAID; Rheumatoid arthritis; Toxicity

Indexed keywords

ACEMETACIN; ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; ANTIRHEUMATIC AGENT; AZAPROPAZONE; DEXIBUPROFEN; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENTIAZAC; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LORAZOLAC; LORNOXICAM; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; RHEUMATOID FACTOR; SUCRALFATE; TENOXICAM; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTPATIENT DEPARTMENT; PROTECTION; RHEUMATOID ARTHRITIS; TIME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR;

EID: 0036050975     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2571.2002.01037.x     Document Type: Article

References (33)

1. Misoprostol compared with sucralfate in the prevention of nonsteroidal antiinflammatory drug-induced gastric ulcer. A randomized, controlled trial
2. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
3. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: A prospective, placebo-controlled, double-blind, parallel-group study
4. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
5. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
6. Nonsteroidal anti-inflammatory drug-associated dyspepsia: The scale of the problem
7. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one- year, randomized, clinical trial in patients with osteoarthritis of the knee and hip
8. Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial
9. The relative toxicity of nonsteroidal antiinflammatory drugs
10. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis
11. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
12. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial
13. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
14. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial
15. Variability in risk of gastrointestinal complications with individual nonsteroidal anti-inflammatory drugs: Results of a collaborative meta- analysis
16. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
17. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
18. Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice
19. The 'side effects' of rheumatoid arthritis: Joint destruction, disability and early mortality
20. Double-blind study evaluating by endoscopy the tolerability of nimesulide and diclofenac on the gastric mucosa in osteoarthritic patients
21. Omeprazole ameliorates aspirin-induced gastroduodenal injury
22. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis
23. Role of inducible cyclooxygenase (COX-2) in inflammation
24. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
25. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial
26. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
27. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs
28. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs
29. Hepatic and renal tolerability of long-term naproxen treatment in patients with rheumatoid arthritis
30. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
31. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
32. Misoprostol for the treatment of peptic ulcer and anti-inflammatory-drug-induced gastroduodenal ulceration